160 related articles for article (PubMed ID: 7907418)
1. A proline-rich transcriptional activation domain in murine HOXD-4 (HOX-4.2).
Rambaldi I; Kovàcs EN; Featherstone MS
Nucleic Acids Res; 1994 Feb; 22(3):376-82. PubMed ID: 7907418
[TBL] [Abstract][Full Text] [Related]
2. Functional differences between HOX proteins conferred by two residues in the homeodomain N-terminal arm.
Phelan ML; Sadoul R; Featherstone MS
Mol Cell Biol; 1994 Aug; 14(8):5066-75. PubMed ID: 7913516
[TBL] [Abstract][Full Text] [Related]
3. Multiple regions of p45 NF-E2 are required for beta-globin gene expression in erythroid cells.
Bean TL; Ney PA
Nucleic Acids Res; 1997 Jun; 25(12):2509-15. PubMed ID: 9171106
[TBL] [Abstract][Full Text] [Related]
4. Functional interaction between a RARE and an AP-2 binding site in the regulation of the human HOX A4 gene promoter.
Doerksen LF; Bhattacharya A; Kannan P; Pratt D; Tainsky MA
Nucleic Acids Res; 1996 Jul; 24(14):2849-56. PubMed ID: 8759021
[TBL] [Abstract][Full Text] [Related]
5. Sequence and expression of the murine Hoxd-3 homeobox gene.
Tan DP; Shao X; Pu L; Guo V; Nirenberg M
Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8247-52. PubMed ID: 8710855
[TBL] [Abstract][Full Text] [Related]
6. A structure-function analysis of transcriptional repression mediated by the WT1, Wilms' tumor suppressor protein.
Madden SL; Cook DM; Rauscher FJ
Oncogene; 1993 Jul; 8(7):1713-20. PubMed ID: 8510918
[TBL] [Abstract][Full Text] [Related]
7. TFE3 contains two activation domains, one acidic and the other proline-rich, that synergistically activate transcription.
Artandi SE; Merrell K; Avitahl N; Wong KK; Calame K
Nucleic Acids Res; 1995 Oct; 23(19):3865-71. PubMed ID: 7479029
[TBL] [Abstract][Full Text] [Related]
8. Functional domains of the heavy metal-responsive transcription regulator MTF-1.
Radtke F; Georgiev O; Müller HP; Brugnera E; Schaffner W
Nucleic Acids Res; 1995 Jun; 23(12):2277-86. PubMed ID: 7610056
[TBL] [Abstract][Full Text] [Related]
9. Transgenic analysis of a potential Hoxd-11 limb regulatory element present in tetrapods and fish.
Beckers J; Gérard M; Duboule D
Dev Biol; 1996 Dec; 180(2):543-53. PubMed ID: 8954726
[TBL] [Abstract][Full Text] [Related]
10. An inhibitor domain in Sp3 regulates its glutamine-rich activation domains.
Dennig J; Beato M; Suske G
EMBO J; 1996 Oct; 15(20):5659-67. PubMed ID: 8896459
[TBL] [Abstract][Full Text] [Related]
11. The Abd-B-like Hox homeodomain proteins can be subdivided by the ability to form complexes with Pbx1a on a novel DNA target.
Shen WF; Rozenfeld S; Lawrence HJ; Largman C
J Biol Chem; 1997 Mar; 272(13):8198-206. PubMed ID: 9079637
[TBL] [Abstract][Full Text] [Related]
12. The Oct-2 glutamine-rich and proline-rich activation domains can synergize with each other or duplicates of themselves to activate transcription.
Tanaka M; Clouston WM; Herr W
Mol Cell Biol; 1994 Sep; 14(9):6046-55. PubMed ID: 8065338
[TBL] [Abstract][Full Text] [Related]
13. GT-2: in vivo transcriptional activation activity and definition of novel twin DNA binding domains with reciprocal target sequence selectivity.
Ni M; Dehesh K; Tepperman JM; Quail PH
Plant Cell; 1996 Jun; 8(6):1041-59. PubMed ID: 8672890
[TBL] [Abstract][Full Text] [Related]
14. AP-2.2: a novel AP-2-related transcription factor induced by retinoic acid during differentiation of P19 embryonal carcinoma cells.
Oulad-Abdelghani M; Bouillet P; Chazaud C; Dollé P; Chambon P
Exp Cell Res; 1996 Jun; 225(2):338-47. PubMed ID: 8660922
[TBL] [Abstract][Full Text] [Related]
15. An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1.
Calvo KR; Knoepfler P; McGrath S; Kamps MP
Oncogene; 1999 Dec; 18(56):8033-43. PubMed ID: 10637514
[TBL] [Abstract][Full Text] [Related]
16. Deletion of a HoxD enhancer induces transcriptional heterochrony leading to transposition of the sacrum.
Zákány J; Gérard M; Favier B; Duboule D
EMBO J; 1997 Jul; 16(14):4393-402. PubMed ID: 9250683
[TBL] [Abstract][Full Text] [Related]
17. Basal components of the transcription apparatus (RNA polymerase II, TATA-binding protein) contain activation domains: is the repetitive C-terminal domain (CTD) of RNA polymerase II a "portable enhancer domain"?
Seipel K; Georgiev O; Gerber HP; Schaffner W
Mol Reprod Dev; 1994 Oct; 39(2):215-25. PubMed ID: 7826625
[TBL] [Abstract][Full Text] [Related]
18. Identification of a putative transactivation domain in human Nanog.
Oh JH; Do HJ; Yang HM; Moon SY; Cha KY; Chung HM; Kim JH
Exp Mol Med; 2005 Jun; 37(3):250-4. PubMed ID: 16000880
[TBL] [Abstract][Full Text] [Related]
19. Identification of an N-terminal transcriptional activation domain within Brn3b/POU4f2.
Martin SE; Mu X; Klein WH
Differentiation; 2005 Feb; 73(1):18-27. PubMed ID: 15733064
[TBL] [Abstract][Full Text] [Related]
20. Wild type PAX3 protein and the PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma contain potent, structurally distinct transcriptional activation domains.
Bennicelli JL; Fredericks WJ; Wilson RB; Rauscher FJ; Barr FG
Oncogene; 1995 Jul; 11(1):119-30. PubMed ID: 7624119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
